Cite
Catalano MG, Pugliese M, Gallo M, et al. Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. Int J Endocrinol. 2016;2016:2930414doi: 10.1155/2016/2930414.
Catalano, M. G., Pugliese, M., Gallo, M., Brignardello, E., Milla, P., Orlandi, F., Limone, P. P., Arvat, E., Boccuzzi, G., & Piovesan, A. (2016). Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. International journal of endocrinology, 20162930414. https://doi.org/10.1155/2016/2930414
Catalano, Maria Graziella, et al. "Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial." International journal of endocrinology vol. 2016 (2016): 2930414. doi: https://doi.org/10.1155/2016/2930414
Catalano MG, Pugliese M, Gallo M, Brignardello E, Milla P, Orlandi F, Limone PP, Arvat E, Boccuzzi G, Piovesan A. Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. Int J Endocrinol. 2016;2016:2930414. doi: 10.1155/2016/2930414. Epub 2016 Sep 27. PMID: 27766105; PMCID: PMC5059567.
Copy
Download .nbib